Oral Lipid Formulation Type IV As an Approach in the Formulation of Solid Dosage Forms With Poorly Soluble Substances: Chremophor®RH 40 As a Surfactant Phase. Progr Nutr 2021, 23 (3), e2021279. https://doi.org/10.23751/pn.v23i3.12071.